Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Valhi, Inc. (VHI)
NYSEMaterialsChemicalsSnapshot 2026-11-04
$15.21+4.11%
Close 2026-11-04 · 1-day change
NYSEMaterialsChemicalsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.56 → 3.56 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for VHI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash from operations improves from negative $46.1M | Dividend payments support cash flow outlook. | Under Pressure | Cash flow stays negative next 4 quarters | Cash from operations: $59.1M FY2026-Q2; GAAP. Published target: >= $0. Target period is not explicitly aligned with this observation. Aug 6, 202659,100,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
VHI is an operational improvement story in a Materials sector with a supportive backdrop, rather than a proven durable compounder. Its multi-year view is intact, but confidence is medium and execution remains fragile.
The evidence describes VHI as expensive, despite a valuation driver that labels it cheap versus peers; the model has low confidence. The expectations gap is negative, and the priced-in assessment says weak execution is recognized, but not a broader stack of risks.
Near term, earnings risk is elevated after consecutive misses, and a guidance cut on the next call would be a meaningful setback. In recent results, Chemicals sales and operating income improved, while total operating income rose between the first and second quarters of 2026; operating cash flow remains uneven. Management’s operating-profit and revenue priorities are on track, but its score recently declined.
The multi-year thesis depends on continued gains in profitability and revenue, alongside steadier cash generation. Near-term results hinge on whether VHI avoids another miss or guidance cut, while sector momentum depends partly on whether DOW, DD, and CE keep reporting strong results and guidance.
Over the next one to three years, VHI’s operating progress supports an intact thesis, but repeated earnings misses, uneven cash flow, and an expensive valuation make execution the central test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Valhi, Inc.'s published investment case. The stated target is >= $2M. |
| Improving |
| Net income falls below zero next quarter |
Net income: $22.3M FY2026-Q2; GAAP. Published target: >= $2M. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 6, 202622,300,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.3 million, or $.78 per share, in the second quarter of 2026 compared to net income of $.9 million, or $.03 per share, in the second quarter of 2025.” “Net income attributable to Valhi stockholders increased in the first six months of 2026 as compared to the same period of 2025 primarily due to improved operating results across all business segments.” Delivery assessment Nov 4, 2026 |
Operating income improves to at least $32.9M next quarter | A primary condition in Valhi, Inc.'s published investment case. The stated target is >= $32.9M. | Intact | Operating income falls below zero next quarter | Operating income: $67.7M FY2026-Q2; GAAP. Published target: >= $32.9M. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 6, 202667,700,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.3 million, or $.78 per share, in the second quarter of 2026 compared to net income of $.9 million, or $.03 per share, in the second quarter of 2025.” “Net income attributable to Valhi stockholders increased in the first six months of 2026 as compared to the same period of 2025 primarily due to improved operating results across all business segments.” Delivery assessment Nov 4, 2026 |
Revenue grows to at least $560.1M next quarter | A primary condition in Valhi, Inc.'s published investment case. The stated target is >= $560.1M. | Intact | Revenue falls below $494.5M next quarter | Revenue: $606.1M FY2026-Q2; GAAP. Published target: >= $560.1M. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 6, 2026606,100,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.56 → $3.56 · observed estimates
$2.06B → $2.06B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-07-25 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-07-26 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-07-27 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-07-28 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-07-29 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-07-30 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-07-31 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-01 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-02 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-03 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-04 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-05 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-06 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-08 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-09 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-10 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-12 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-13 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-14 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-15 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-16 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-17 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-18 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-19 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-20 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-21 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-22 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-23 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-24 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-25 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-26 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-27 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-28 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-29 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-30 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-08-31 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-01 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-02 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-03 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-04 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-05 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-06 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-07 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-08 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-09 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-10 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-11 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-12 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-13 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-14 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-15 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-16 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-17 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-18 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-19 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-20 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-21 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-22 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-23 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-24 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-25 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-26 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-27 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-28 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-29 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-09-30 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-01 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-02 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-03 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-04 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-05 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-06 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-07 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-08 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-09 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-10 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-11 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-12 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-13 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-14 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-15 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-16 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-17 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-18 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-19 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-20 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-21 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-22 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-23 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-24 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-25 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-26 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-27 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-28 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-29 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-30 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-10-31 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-11-01 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-11-02 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-11-03 | $3.56 | $2,064,913,343 | 1 / 1 |
| 2026-11-04 | $3.56 | $2,064,913,343 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.